Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPADE study of dienogest versus low-dose estrogen-progestin effects on protein S activity in endometriosis
jRCTs071180042Completed
- Sponsor
- Mochida Pharmaceutical Co., Ltd.
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dienogest in endometriosis (2 arms), sponsored by Mochida Pharmaceutical Co., Ltd. Primary endpoint: Change in protein S specific activity. Started Jun 2016; status: completed.
02
Drugs
dienogest
03
Conditions
endometriosis
Beyond the preview
Go deeper on jRCTs071180042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071180042.